JNCE - Jounce Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5244.38M
Enterprise Value 3-10.02M
Trailing P/E N/A
Forward P/E 1-6.14
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.91
Price/Book (mrq)2.20
Enterprise Value/Revenue 3-0.16
Enterprise Value/EBITDA 60.35

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin -47.73%
Operating Margin (ttm)-52.34%

Management Effectiveness

Return on Assets (ttm)-6.42%
Return on Equity (ttm)-20.72%

Income Statement

Revenue (ttm)62.55M
Revenue Per Share (ttm)1.94
Quarterly Revenue Growth (yoy)-44.80%
Gross Profit (ttm)38.82M
EBITDA -28.33M
Net Income Avi to Common (ttm)-29.86M
Diluted EPS (ttm)-0.93
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)237.18M
Total Cash Per Share (mrq)7.31
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.63
Book Value Per Share (mrq)3.40

Cash Flow Statement

Operating Cash Flow (ttm)-94.42M
Levered Free Cash Flow (ttm)-51.5M

Trading Information

Stock Price History

Beta N/A
52-Week Change 3-47.56%
S&P500 52-Week Change 316.98%
52 Week High 329.25
52 Week Low 36.56
50-Day Moving Average 37.58
200-Day Moving Average 315.54

Share Statistics

Avg Vol (3 month) 3649.62k
Avg Vol (10 day) 3361.77k
Shares Outstanding 532.63M
Float 13.5M
% Held by Insiders 115.37%
% Held by Institutions 190.06%
Shares Short (Jul 13, 2018) 44.17M
Short Ratio (Jul 13, 2018) 48.77
Short % of Float (Jul 13, 2018) 426.73%
Short % of Shares Outstanding (Jul 13, 2018) 412.85%
Shares Short (prior month Jun 15, 2018) 44.66M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A